Overamping: Psychostimulant Overdose

Overamping: Psychostimulant Overdose (Part of the Harm Reduction Series) 

The Harm Reduction series consists of 11 stand-alone training sessions for healthcare providers and substance use disorder (SUD) treatment teams, aiming to help them better understand Harm Reduction principles and harm reduction strategies as best practice in SUD treatment. Each training session, led by a Boston Medical Center Grayken TTA clinical educator and an expert community member with boots-on-the-ground experience in the specific topic area, will provide an hour-long didactic and a 30-minute Q&A. Participants may attend all training sessions or select specific ones.
 

The overamping training  teaches strategies for identifying patients experiencing a stimulant overdose and caring for patients experiencing acute psychosis secondary to psychostimulant ingestion. We will focus on warning signs of psychostimulant overdose and strategies to mitigate the harm associated with the patient’s psychotic state, including de-escalation techniques in clinical and community settings.

Learning Objectives 

• Review the epidemiology of stimulant use in the United States and the corresponding risk of psychostimulant overdose.
• Identify the signs and symptoms of overamping.
• Employ the AGRO+ de-escalation strategy for patients experiencing overamping.
• Devise strategies to reduce the risks of overamping as well as contingency plans for what to do if overamping should occur.
• Recognize the medical and psychological risks associated with overamping.

Learn more & register

For trainings that indicate Continuing Education Units (CEUs) are available, contact the organizer and/or the Vermont Office of Professional Regulation to verify that the credits will count toward the continuing education requirements of your licensure or certification.